Journal
CELL CHEMICAL BIOLOGY
Volume 26, Issue 3, Pages 433-+Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2018.11.015
Keywords
-
Categories
Funding
- NIH [K01DK116917, R01GM020501, R01DK105961, U19AI135972, P30DK063491, U54 GM069338, R01HL134168, R01DK112940, R01HL134811, K24HL136852, R01CA199376, S10OD020025, R03AG053287, R01ES027595]
- NHLBI [N01HC25195, HHSN268201500001I]
- American Heart Association
- Doris Duke Charitable Foundation [2015092]
- Tobacco-Related Disease Research Program [24RT-0032, 24FT-0010]
- UC San Diego Frontiers of Innovation Scholars Program
- Emil Aaltonen Foundation
- Finnish Medical Foundation
- Paavo Nurmi Foundation
Ask authors/readers for more resources
Eicosanoids and related oxylipins are critical, small bioactive mediators of human physiology and inflammation. While similar to 1,100 distinct species have been predicted to exist, to date, less than 150 of these molecules have been measured in humans, limiting our understanding of their role in human biology. Using a directed non-targeted mass spectrometry approach in conjunction with chemical networking of spectral fragmentation patterns, we find over 500 discrete chemical signals highly consistent with known and putative eicosanoids and related oxylipins in human plasma including 46 putative molecules not previously described. In plasma samples from 1,500 individuals, we find members of this expanded oxylipin library hold close association with markers of inflammation, as well as clinical characteristics linked with inflammation, including advancing age and obesity. These experimental and computational approaches enable discovery of new chemical entities and will shed important insight into the role of bioactive molecules in human health and disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available